SourcingAI
Try for free
Powered by Made-in-China.com
Reduced Glutathione for Injection with GMP From Reyoung
US$0.80
80,000 vials

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Intravenous Injection

Model NO.

0.3g/0.6g/1.2g

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Packaging

1/10/50vial/Box

Standard

Cp/Bp

Transport Package

Box

Specification

0.3g/0.6g/1.2g

Trademark

Reyoung

Origin

No. 1 Ruiyang Road, Yiyuan County, Shandong

Key features

GMP Certified Manufacturing: Produced in a GMP-compliant facility ensuring high pharmaceutical standards.
Multiple Dosage Options: Available in 0.3g, 0.6g, and 1.2g specifications for flexible clinical use.
Liver Protection Indication: Provides protective effects against liver damage caused by various factors.
Chemotherapy Drug Support: Used for prevention and treatment of side effects from chemotherapy and anti-tuberculosis drugs.
Customizable Packaging: Packaging options available in 1, 10, or 50 vials per box.
OEM and ODM Services: Full OEM and ODM services available for custom branding and formulation.
Broad Patient Applicability: Suitable for elderly, children, and adult populations.
Established Manufacturer: Manufacturer established in 1998 with over 4900 employees and 370 R&D engineers.

Company profile

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 1997-01-01 CertifiedNearest Port: Qingdao PortAverage Response Time: >24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryREYOUNG PHARMACEUTICAL CO., LTD. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The supplier reports ISO 9001, ISO 14001, and OHSAS 18001 certifications, more than 10 production lines, 50 quality-control staff, and 370 years of combined R&D-engineer experience. Its stated manufacturing portfolio includes sterile raw materials, powders and liquids for injection, tablets, and capsules, with reported annual production above the stated threshold. The company identifies three factories, an extensive manufacturing area, international business since 1997, and export markets across South America, Africa, Southeast Asia, and the Middle East. Trade records show transactions involving India, Bolivia, and Vietnam, including cefotaxime-related products. Evidence is insufficient to assess after-sales service, financial credibility, innovation output, or customization capability. Customer-case evidence is limited to named buyers and trade records.
Supplier typeThe supplier is identified as a combined business entity and a limited company headquartered in Shandong, China. Its business scope is health and medicine, with products including sterile raw materials, injectable products, tablets, and capsules, supporting classification as a pharmaceutical manufacturer and distributor.
CertificationsThe supplier explicitly reports ISO 9001:2015, ISO 14001:2015, and OHSAS 18001:2007 certificates, and separately describes itself as GMP and ISO authenticated. These stated certifications provide direct evidence of formal quality, environmental, and occupational-health management systems.
Production capacityProduction capacity is supported by more than 10 production lines, three factories, a reported manufacturing area of 1,000,000 square meters, and stated annual output across small-volume injections, powder injections, tablets, and capsules. The supplier also reports annual production above the stated threshold, indicating substantial multi-form pharmaceutical manufacturing capability.
Client casesTrade records identify transactions involving STERILE INDIA PRIVATE LIMITED, HEREDIA ARACENA RENY EVELIN, and a Vietnam-related registration, with products including cefotaxime-related material and oral rehydration products. These records demonstrate some international commercial activity, but the evidence is limited and does not establish long-term customer performance or a broad verified customer portfolio.

Product Q&A

Q:What are the available specifications for this product?
A:
The product is available in 0.3g, 0.6g, and 1.2g specifications.
Q:What is the primary medical use of Reduced Glutathione?
A:
It is used for the prevention and treatment of side effects from chemotherapy, anti-tuberculosis, and psychotropic drugs, as well as radiation therapy and alcohol poisoning.
Q:Does this product offer liver protection?
A:
Yes, it has protective effects on liver damage caused by various causes.
Q:Can the packaging be customized?
A:
Yes, packaging is customizable with options for 1, 10, or 50 vials per box.
Q:What standards does the product meet?
A:
The product meets Cp and Bp standards.

Send Inquiry

*To:REYOUNG PHARMACEUTICAL CO., LTD.REYOUNG PHARMACEUTICAL CO., LTD.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like

Naclo3 99.5% Induatry Grade Sodium Hypochlorite
Made-in-China.com